P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy ; volume:13 ; number:1 ; day:21 ; month:5 ; year:2014 ; pages:1-7 ; date:12.2014
Molecular cancer ; 13, Heft 1 (21.5.2014), 1-7, 12.2014
- Creator
-
Zhang, Ding-Guo
Zheng, Jun-Nian
Pei, Dong-Sheng
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1476-4598-13-115
- URN
-
urn:nbn:de:101:1-2021082907513743355325
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhang, Ding-Guo
- Zheng, Jun-Nian
- Pei, Dong-Sheng
- SpringerLink (Online service)
Other Objects (12)
Erratum to: Metabolic regulation by p53
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
P53 regulated microRNAs in colorectal cancer
Kayadiol exerted anticancer effects through p53-mediated ferroptosis in NKTCL cells
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines
Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
Anticancer activity of quantum size carbon dots: opportunities and challenges
The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines
The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines
Surface-modified cobalt oxide nanoparticles: new opportunities for anti-cancer drug development
Erratum to: Metabolic regulation by p53
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
P53 regulated microRNAs in colorectal cancer
Kayadiol exerted anticancer effects through p53-mediated ferroptosis in NKTCL cells
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines
Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
Anticancer activity of quantum size carbon dots: opportunities and challenges
The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines
The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines
Surface-modified cobalt oxide nanoparticles: new opportunities for anti-cancer drug development
Erratum to: Metabolic regulation by p53
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
P53 regulated microRNAs in colorectal cancer
Kayadiol exerted anticancer effects through p53-mediated ferroptosis in NKTCL cells
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines
Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
Anticancer activity of quantum size carbon dots: opportunities and challenges
The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines
The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines